Rigaku Raman Technologies Handheld Raman Analyser Progeny Wins IBO Award for Portable Analytical Instrument Industrial Design
Rigaku Raman Technologies, a leading pioneer of handheld and portable Raman spectrometers, is delighted to announce that its handheld Raman analyser, Progeny has received the Bronze Award for the Portable Analytical Instrument Industrial Design category in the 2014 Instrument Business Outlook (IBO) Design Awards. Progeny represents the new generation in handheld Raman analysis for comprehensive material identification and analysis across applications including raw material identification in the pharmaceutical industry and chemical detection for first responders.
The annual IBO Awards recognise excellence in the industrial design of analytical instruments, portable analytical instruments and laboratory equipment. Judged on innovation, functionality and product features, the winners were selected based on designs that improve product functionality and the end-user experience. In the Portable Analytical Instrument Industrial Design category, winning products were not only chosen for being compact and stylish but also how they address the unique challenges of doing analysis outside of the laboratory.
Progeny is designed to provide superior performance, design and usability for the identification of unknown materials. Weighing just 3.5 lbs, Progeny’s lightweight aluminum housing is sealed against moisture, dust and other potential contaminants to prevent contamination and enables use in any environment with an IP-68 protection rating. The ergonomics of the instrument were carefully considered to provide a comfortable user experience and Progeny’s user-friendly angled display, touchscreen interface provides easy, single-hand use. Compared to other handheld Raman analysers, Progeny provides enhanced performance capabilities for the measurement of colored materials or through dark containers by eliminating fluorescence interference with the use of a unique 1064-nm laser.
Bree Allen, VP and General Manager at Rigaku Raman Technologies, commented on the award win: “We are delighted that Progeny has been recognised with this prestigious award. With Progeny, we exceeded all of our initial expectations by redefining the performance, ruggedness and ease of use that can be experienced when using handheld Raman for material identification. Rigaku Raman is committed to setting new benchmarks in Raman spectroscopy. With Progeny, we have developed a product that we believe will revolutionise what can be achieved with handheld Raman across a multitude of applications.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance